Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: FEBS J. 2013 Feb 15;280(10):2353–2368. doi: 10.1111/febs.12148

Fig. 6.

Fig. 6

Diagram depicting the role of decorin in inducing rapid release of thrombospondin-1 (TSP-1) from breast cancer cells via the EGFR. Soluble decorin functions as a partial agonist of EGFR to elicit RhoA degradation via the 26S proteasome. Loss of RhoA leads to deactivation of ROCK1 signaling and mobilization of TSP-1-enriched vesicles. This novel decorin-evoked bioactivity is mediated exclusively through the EGFR but not via the Met receptor. Please refer to text for additional details.